Search

for
Search:

Research

3 / 1000+ results

research 44047 Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry

September 2023 in “Journal of the American Academy of Dermatology”

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Ixekizumab Shows Efficacy and Safety in Patients Who Failed Biweekly Etanercept Therapy: Analysis From UNCOVER-2, a Phase 3 Randomized Clinical Trial in Psoriasis

research Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis

April 2016 in “Journal of The American Academy of Dermatology”

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

research Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab

21 citations , September 2019 in “Journal of the American Academy of Dermatology”

Ixekizumab effectively treats generalized pustular psoriasis.

View more "pasi90" in research →

Learn

— no results

Try a deeper search in learn →

Community Join

— no results

Try a deeper search in community →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →